F
Fumihiko Urano
Researcher at Washington University in St. Louis
Publications - 149
Citations - 18195
Fumihiko Urano is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Unfolded protein response & Endoplasmic reticulum. The author has an hindex of 48, co-authored 133 publications receiving 16108 citations. Previous affiliations of Fumihiko Urano include University of Massachusetts Boston & University of Massachusetts Amherst.
Papers
More filters
Journal ArticleDOI
Endoplasmic Reticulum: An Interface Between the Immune System and Metabolism
Emil R. Unanue,Fumihiko Urano +1 more
TL;DR: The role of ER as an interface between the immune system and metabolism is an emerging concept and indicates that inherited or acquired dysregulation of ER homeostasis can give rise to genetic diseases and common metabolic diseases.
Journal ArticleDOI
Islet cell hyperplasia in transgenic mice overexpressing EAT/mcl-1, a bcl-2 related gene
Kenichi Matsushita,Hajime Okita,Atsushi C. Suzuki,Kouji Shimoda,Mariko Fukuma,Taketo Yamada,Fumihiko Urano,Takahiro Honda,Makoto Sano,Shiro Iwanaga,Satoshi Ogawa,Jun-ichi Hata,Akihiro Umezawa +12 more
TL;DR: EAT may inhibit apoptosis of beta cells, allowing these cells to circumvent the process of apoptosis until the adult stage, and EAT transgenic mice exhibit hyperplasia of pancreatic beta cells.
Journal ArticleDOI
Monogenic and syndromic diabetes due to endoplasmic reticulum stress.
TL;DR: The phenotypes and molecular pathogenesis of ERstress-related monogenic forms of diabetes related to ER dysregulation are described to understand the exact contribution of ER stress to β-cell death and to develop personalized genetic medicine for ER stress-related diabetic disorders, such as Wolfram syndrome.
Journal ArticleDOI
corrigendum: IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA
Marcella Calfon,Huiqing Zeng,Fumihiko Urano,Jeffery H. Till,Stevan R. Hubbard,Heather P. Harding,Scott G. Clark,David Ron +7 more
TL;DR: In this article, the commercial polyclonal antiserum used to detect endogenous XBP-1 was sc-7160 (Santa Cruz Biotechnology) and not sc-8015, as erroneously stated.
Journal ArticleDOI
Maternal uniparental disomy of chromosome 4 and homozygous novel mutation in the WFS1 gene in a paediatric patient with Wolfram syndrome.
Dimitrios T Papadimitriou,Emmanouil Manolakos,C. Bothou,George Zoupanos,Ioannis Papoulidis,Sandro Orru,Filippos Skarmoutsos,Alexander Delides,C. Bakoula,Anastasios Papadimitriou,Fumihiko Urano +10 more
TL;DR: Diabetes & Metabolism - In Press.